patient-centered care

Research in Review

Vinblastine for Low-Grade Glioma Has Few Side Effects and Comparable Survival

09/09/2016

JCP Editors

Vinblastine monotherapy has similar outcomes and a more favorable toxicity profile compared with current therapies when used in patients with treatment naïve pediatric low-grade glioma (PLGG), according to a study...

...

09/09/2016

Journal of Clinical Pathways

Quiz

Friday Morning Quiz: Week of September 4-10

09/08/2016

JCP Editors

In a Viewpoint found in the most recent issue of Journal of Clinical Pathways, Dr Stephen McKenna contends that oncology patient-reported outcome measures (PROMs) are restrictive because they focus too much on a...

In a...

09/08/2016

Journal of Clinical Pathways

Counterpoint

The Pivot Toward Patient-Centeredness in Medicine and Oncology

09/06/2016

Jennifer Fillman , MBA;

Julia Braverman , PhD;

Bruce A. Feinberg , DO;

Patient-reported outcome (PRO) research has shown that PROs must play a role in the future of health care delivery as the system transitions from volume-based care to value-based care. Building trust among...

...

09/06/2016

Journal of Clinical Pathways

Viewpoint

The Limitations of Patient-Reported Outcome Measurement in Oncology

09/06/2016

Stephen P. McKenna , PhD, AFBPsS, CPsychol;

Generic patient-reported outcome measures (PROMs) for cancer have outlived their utility. More relevant and accurate PROMs are required in order to demonstrate the true value of oncology interventions to...

...

09/06/2016

Journal of Clinical Pathways

Counterpoint

When Determining Value in Cancer Care, Don`t Forget the Patient

12/14/2015

Joan S. McClure , MS;

Al B. Benson III, MD, FACP, FASCO;

Before the relative value of a drug can be determined, one must first consider how value is defined by the patient. Cancer care is expensive, and evaluating costs in cancer care is complex. Drug costs are only part...

Before...

12/14/2015

Journal of Clinical Pathways